ArticleAnnals of hematology2022

Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation.

Peng Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.